Welcome to CDC stacks | Antibody Testing and Lyme Disease Risk - 15614 | Emerging Infectious Diseases | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Antibody Testing and Lyme Disease Risk
Filetype[PDF-288.05 KB]


Details:
No Related Documents.
You May Also Like:
  1. Lyme disease surveillance summary volume 6, no. 2, November 1995
    Corporate Author:
    National Center for Infectious Diseases (U.S.). Division of Vector-Borne Infectious Diseases. Bacterial Zoonoses Branch.
    Published:
    November 1995
    Series:
    Lyme disease surveillance summary ; v. 6, no. 2
    Description:
    Includes reprint of: Lyme disease--United States, 1994. MMWR Morb Mortal Wkly Rep. 1995 Jun 23;44(24):459-62.
    File Type:
    Filetype[PDF - 5.15 MB]
  2. Tickborne diseases of the United States : a reference manual for health care providers. Fifth edition, 2018
    Corporate Author:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.
    Published:
    6/8/18
    Description:
    Based on “Tickborne Diseases in Massachusetts: A Physician’s Reference Manual,” produced by collaboration between MDPH, Nancy Shadick, MD, MPH, and : Nancy Maher, MPH of the RBB Arthritis and Musculoskeletal Diseases Clinical Research Center at...
    File Type:
    Filetype[PDF - 2.48 MB]
  3. Current Guidelines, Common Clinical Pitfalls, and Future Directions for Laboratory Diagnosis of Lyme Disease, United States
    Personal Author:
    Moore, Andrew; Nelson, Christina; Molins, Claudia; Mead, Paul; Schriefer, Martin;
    Published:
    Jul 2016
    Source:
    Emerg Infect Dis. 22(7):1169-1177.
    Description:
    In the United States, Lyme disease is caused by Borrelia burgdorferi and transmitted to humans by blacklegged ticks. Patients with an erythema migrans lesion and epidemiologic risk can receive a diagnosis without laboratory testing. For all other pat...
    File Type:
    Filetype[PDF - 1.38 MB]
  4. Tickborne diseases of the United States : a reference manual for health care providers. Fouth edition, 2017
    Corporate Author:
    National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases.; Centers for Disease Control and Prevention (U.S.);
    Published:
    fourth edition, 2017
    Description:
    Based on “Tickborne Diseases in Massachusetts: A Physician’s Reference Manual”, produced by collaboration between MDPH, Nancy Shadick, MD, MPH, and Nancy Maher, MPH of the RBB Arthritis and Musculoskeletal Diseases Clinical Research Center at B...
    Status:
    superseded
    File Type:
    Filetype[PDF - 9.02 MB]
  5. Lyme Disease Testing by Large Commercial Laboratories in the United States
    Personal Author:
    HINCKLEY, ALISON F.; CONNALLY, NEETA P.; MEEK, JAMES I.; JOHNSON, BARBARA J.; KEMPERMAN, MELISSA M.; FELDMAN, KATHERINE A.; WHITE, JENNIFER L.; MEAD, PAUL S.;
    Published:
    May 30 2014
    Source:
    Clin Infect Dis. 59(5):676-681.
    Description:
    Background : Laboratory testing is helpful when evaluating patients with suspected Lyme disease (LD). A two-tiered antibody testing approach is recommended, but single-tier and non-validated tests are also used. We conducted a survey of large commerc...
    File Type:
    Filetype[PDF - 115.72 KB]